Actavis and Valeant announced that the FDA has approved Metronidazole 1.3% Vaginal Gel for the treatment of bacterial vaginosis. In April 2013, Actavis acquired the rights to Metronidazole 1.3% from ...
Alembic Pharmaceuticals’ joint venture, Aleor Dermaceuticals, has received approval from the Food and Drug Administration for its generic Metrogel Gel (metronidazole gel, 1%). The topical gel is ...
DUBLIN and LAVAL, Quebec — Actavis and Valeant Pharmaceuticals International announced that the Food and Drug Administration approved the new drug application for Metronidazole 1.3% vaginal gel. The ...
CHICAGO – Application of a new formulation of azelaic acid gel to the face reduces the redness and lesions associated with rosacea better than a commonly used treatment (metronidazole gel), according ...
Positive Results of Phase 4 Clinical Study Evaluating Effects of Oracea Capsules, 40 mg, in Combination with MetroGel® (metronidazole gel), 1%, as Treatment for Rosacea Presented at Annual Meeting of ...
March 26, 2003 (San Francisco) — Results of a head-to-head open-label trial comparing azelaic acid 15% to metronidazole standard therapy for the treatment of moderate papulopustular facial rosacea ...
BV usually recurs (meaning, it comes back). Up to 66% percent of women with bacterial vaginosis will have it again within a ...
CINCINNATI--(BUSINESS WIRE)--Prasco Laboratories, a Cincinnati-based pharmaceutical company, announced today it has entered into a distribution and supply agreement with Graceway Pharmaceuticals, LLC.
HAWTHORNE, N.Y., July 18, 2006 (PRIMEZONE) -- Taro Pharmaceutical Industries Ltd. (Nasdaq:TARO) reported today that it has received approval from the U.S. Food and Drug Administration for its ...
Diagnosis of BV in the nearby future will definitely continue to rely on standardized clinical criteria that can be assessed rapidly as a point-of-care test by the attending physician. It is even ...
Background: Women with cervicitis frequently have bacterial vaginosis (BV). Prior studies have suggested that BV is involved in the pathogenesis of cervicitis. Goals: To delineate the association of ...
(Reuters Health) - Researchers say they have cut the recurrence rate of bacterial vaginosis by one third using an experimental treatment that injects a bacterium known as Lactin-V into the vagina to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback